Search Results

81 - 90 of 282 items :

  • pharmacokinetics x
  • Clinical Medicine x
Clear All
Updates on the Treatment of Pterygium

. (1991). Lipophilicity, solubility and permeability of loteprednol etabonate: a novel, soft anti-inflammatory steroid. J Biopharm Sci. 2(2):115-25. 32. Wu WM, Huang F, Lee Y, Buchwald P, Bodor N. (2008). Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats. J Pharm Pharmacol. 60(3):291-7. 33. Nguyen HT, Samudre SS, Lattanzio FA, Williams PB, Sheppard JD. (2008). Loteprednol etablonate reduces Inflammatory Response associated with Pterygium Progression. Investig Ophthalmol Vis Sci 49: 6027. 34. Karalezli A, Kucukerdonmez C

Open access
Original Article. Study of the cytotoxic/toxic potential of the novel anticancer selenodiazoloquinolone on fibroblast cells and 3D skin model

-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers. Antimicrobiol Agents Chemother 54: 411-417. Jantová S, Letašiová S, Koňariková K, Milata V, Brezová V. (2010). Eff ect of new synthetically prepared quinolone ethyl-1,4-dihydro-8-nitro-4-oxoquinoline-3-carboxylate on human leukemia cell line HL-60 without/with presence of UVA irradiation. Acta Chimica Slovaca 3: 51-72. Jantová S, Koňariková K, Letašiová S, Paulovičová E, Milata V, Brezová V. (2011). Photochemical and phototoxic properties of

Open access
Ovarian cancer: early detection, angiogenesis, lymphangiogenesis and current prospects for therapy

target antigens for immunodiagnosis and immunotherapy in ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1990;36:221-8. 41. Coliva A, Zacchetti A, Luison E, et. al. 90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas. Cancer Immunol Immunother. 2005;54:1200-13. 42. Rosenblum M, Shawver L, Marks J, et. al. Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft

Open access
Local Anesthesia in Pediatric Patients – a Review of Current and Alternative Methods, Devices and Techniques

;25(3):215-9. 8. Peedikayil F, Vijayan A. An update on local anesthesia for pediatric dental patients. Anesth Essays Res 2013;7(1):4-9. 9. Meechan JG, Donaldson D. The intraoral use of EMLA cream in children: a clinical investigation. ASDC J Dent Child 61(4):260-2. 10. Ciancio SG, Hutcheson MC, Ayoub F, et al. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia. J Dent Res 2013;92(7 Suppl): 43S-8S. 11. Giannakopoulos H, Levin LM, Chou JC, et al. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline

Open access
Urethritis and antimicrobial resistance

(1):6-8. 27. Golparian D, Fernandes P, Ohnishi M, Jensen JS, Unemo M. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with various high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother 2012;56(5):2739-42. 28. Still JG, Schranz J, Degenhardt TP, Scott D, Fernandes P, Gutierrez MJ, et al. Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses

Open access
Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts

from tunisian pomegranate (Punica granatum). Fruits Journal of Food Science   76 : C707-C713. Wang R, Ding Y, Liu R, Xiang L, Du L. (2010). Pomegranate: constituents, bioactivities and pharmacokinetics. fruit, Vegetable and Cereal Science and Biotechnology Special Issue 2 : 77-87. Yabe-Nishimura C. (1998). Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev   50 : 21-33. Zahin M, Aqil F, Ahmad I. (2010). Broad spectrum

Open access
Clinical and Economic Outcomes of New Oral Anticoagulants in Orthopaedics

.1302/0301-620X.90B2.20106. 8. Bass AR. (2015). Using new oral anticoagulants in patients undergoing major orthopedic surgery. Curr Rheumatol Rep. 17(4), 25. DOI: 10.1007/s11926-015-0498-z. 9. Eriksson BI, Quinlan DJ, Weitz JI. (2009). Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development. Clin Pharmacokinet. 48(1), 1-22. DOI: 10.2165/0003088-200948010-00001. 10. Wong PC, Crain EJ, Pinto DJ, Watson CA. (2007). Dose-Dependent Antithrombotic Effects of Apixaban, an Oral Direct Factor Xa Inhibitor, in

Open access
Physiochemical basis of human degenerative disease

, Genuis SJ, Frye RE. (2014). Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry 4 : e360. Sato A, Nakajima T. (1987). Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand J Work Environ Health 13 : 81–93. Schwingshacki L, Hoffmann G. (2014). Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer 135 (8): 1884–97. Scinicariello F, Buser MC. (2014). Urinary polycyclic aromatic hydrocarbons and childhood

Open access
Decreased activity and accelerated apoptosis of neutrophils in the presence of natural polyphenols

Essent Fatty Acids 70: 521-528. Remsberg CM, Yańez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. (2008). Pharmacometrics of Pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, antiinfl ammatory, antioxidant and analgesic activity. Phytother Res 22: 169-179. Richard N, Porath D, Radspieler A, Schwager J. (2005). Eff ects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes. Mol Nutr Food Res 49: 431-442. Robinson

Open access
Type 1 Diabetes in the Young: Organization of two National Centers in Israel and Slovenia / Sladkorna Bolezen Tipa 1 Pri Otrocih in Mladostnikih: Organizacija Dela V Dveh Nacionalnih Centrih V Izraelu in Sloveniji

basal-bolus therapy: treat-totarget study in children and adolescents with type 1 diabetes. Pediatr Diabetes 2013; 14: 196-202. 42. Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S. et al. Liraglutide’s safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Technol Ther 2014; 16: 679-87. 43. Lebenthal Y, Lazar L, Benzaquen H, Shalitin S, Phillip M. Patient perceptions of using the OmniPod system compared with

Open access